RT Journal Article SR Electronic T1 Regulation of Phenylethanolamine N-Methyltransferase Synthesis and Degradation JF Molecular Pharmacology JO Mol Pharmacol FD American Society for Pharmacology and Experimental Therapeutics SP 490 OP 501 VO 14 IS 3 A1 ROLAND D. CIARANELLO A1 DONA L. WONG A1 DAVID M. BERENBEIM YR 1978 UL http://molpharm.aspetjournals.org/content/14/3/490.abstract AB The levels of rat adrenal phenylethanolamine N-methyltransferase fall dramatically following hypophysectomy and can be restored to normal values by the administration of adrenocorticotrophin or glucocorticoids. Studies using combined radiolabeling and immunochemical techniques reveal that hypophysectomy accelerates degradation of the enzyme and that proteolysis of the enzyme in vivo is under regulation by glucocorticoids. After hypophysectomy the stability of phenylethanolamine N-methyltransferase at 50° is profoundly reduced, suggesting that concomitant with the increased susceptibility of the enzyme to proteolysis in vivo is an enhanced vulnerability to thermal denaturation in vitro. The thermal stability of the enzyme seems to be regulated by a freezing-thawinglabile, dialyzable substance present in the adrenal glands of normal rats. This material, termed stabilizing factor, is lost after hypophysectomy and can be restored by the administration of ACTH or dexamethasone. The stabilizing factor appears to act by binding to phenylethanolamine N-methyltransferase and can be dissociated from the immunoadsorbed enzyme by washing. The partially purified stabilizing factor has an absorption maximum at 264 nm; preliminary results indicate that it may be S-adenosylmethionine. Thus it is possible that binding of the enzyme to S-adenosylmethionine confers stability against proteolysis in vivo and thermal denaturation in vitro.